Related Experiment Video
Updated: Nov 28, 2025
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.8K
Paediatric Molecular Radiotherapy: Challenges and Opportunities
M D Aldridge1, C Peet2, S Wan3
1Department of Oncology, University College London Hospitals NHS Foundation Trust, London, UK; Department of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, UK.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|November 28, 2020
Summary
Paediatric molecular radiotherapy (pMRT) shows promise for treating cancers like thyroid cancer and neuroblastoma. Overcoming challenges in accessibility and research funding is key to unlocking its full potential for improved patient outcomes.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiotherapy
Background:
- Paediatric molecular radiotherapy (pMRT) is a precision therapy primarily used for differentiated thyroid cancer and neuroblastoma.
- Its unique mechanism and safety profile offer advantages over conventional treatments.
- Despite its potential, pMRT faces challenges in accessibility and research investment.
Purpose of the Study:
- To provide an overview of the current status of paediatric molecular radiotherapy (pMRT).
- To identify barriers hindering the progress and wider adoption of pMRT.
- To explore strategies for overcoming these obstacles and advancing pMRT applications.
Main Methods:
- Review of current clinical applications and research landscape of pMRT.
- Analysis of challenges including limited specialized centers, accessibility issues, and suboptimal research funding.
- Discussion of emerging opportunities, increased funding, and new clinical trials.
Main Results:
- pMRT is a safe and effective biomarker-driven therapy for specific paediatric cancers.
- Significant barriers include limited treatment centers, geographical disparities, and historical underfunding of research.
- Growing interest and new research initiatives are emerging, with potential for curative applications.
Conclusions:
- Paediatric molecular radiotherapy (pMRT) holds significant promise but requires optimized therapeutic strategies and personalized delivery.
- Addressing accessibility and increasing research investment are crucial for expanding its use.
- New clinical trials and technical advancements are paving the way for pMRT to transition towards curative protocols.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
117
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
117
02:57Targeted Cancer Therapies
8.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.2K
02:56Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K